Author

Anthony Monti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Akshay Salegaonkar· 1 shared Alejandra Macias-GarciaiD· 1 shared Atli ThorarenseniD· 1 shared Cameron C. TrenoriD· 1 shared Cassie Hei· 1 shared Chi Hua Sarah Lin· 1 shared Colin DineriD· 1 shared Corey E. HayfordiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Akshay Salegaonkar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

DCN1 inhibitor induces fetal hemoglobin through self-limited regulation of CUL3 neddylation

Samuel A. Miller, Anthony Monti, Enhua H. Zhou, Chi Hua Sarah Lin, Orna Lynch, Sayani Mukherjee, Cassie Hei, Robert Nicewonger, Colin Diner, Alejandra Macias-Garcia, Kristen A. Marino, Na Li, Ravi K. Ujjinamatada, Akshay Salegaonkar, Sunil Kuppasani, , Sriram Krishnamoorthy

The paper identifies DCN1 as a therapeutic target for beta-hemoglobinopathies by showing its inhibition increases fetal hemoglobin through selective chromatin changes without cytotoxicity.

bioRxiv · Apr 24, 2026 · PreprintMolecular Biology